Lupus nephritis-related issues during COVID-19 pandemic quarantine

Abstract

Get full access to this article

View all access options for this article.

References

Silva

Queiroz

Fonseca

CdB

, et al. Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic. Clinics (Sao Paulo) 2020; 75: e1931.

Sawalha

AH.

Patients with lupus are not protected from COVID-19. Ann Rheum Dis 2020.

Carbillon

Benbara

Boujenah

Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. Epub ahead of print 2020. DOI: 10.1136/annrheumdis-2020-217847.

Mathian

Mahevas

Rohmer

, et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis 2020; 79: 837–839.

Pedrosa

Pasoto

Aikawa

, et al. Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis. Lupus 2020; 29: 560–568.

Petri

Orbai

Alarcón

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.